David O. Walterhouse, MD

Section Head, Oncology; Attending physician, Hematology/Oncology; Richard A. Perritt, MD Professorship in Cancer and Blood Disorders

Associate Professor of Pediatrics, Northwestern University Feinberg School of Medicine

Interim Director, Cancer Biology & Epigenomics Program, Stanley Manne Children's Research Institute

Appointments & Referrals

1.800.543.7362 (1.800.KIDS DOC)

About Me

Clinical Interests: Differentiation and development, molecular oncogenesis, sarcoma treatment, solid tumor therapy

Specialties, Programs & Conditions

Specialties:

Hematology & Oncology

Education & Training

Education: University of Michigan, 1983

Postgraduate Training: Children's Hospital of Philadelphia, 1989, 1986, 1984

Board Certifications: Pediatric Hematology-Oncology, General Pediatrics

See Northwestern University Faculty Profile >

Research

Research Interests: Cancer biology; developmental biology; oncology; pediatrics; signal transduction

Northwestern Scholars Profile >

Publications

Most recent publications

Cardiac-Sparing Whole Lung IMRT in Patients With Pediatric Tumors and Lung Metastasis: Final Report of a Prospective Multicenter Clinical Trial Int J Radiat Oncol Biol Phys103 (1): 28-37
Treatment Approach and Outcomes in Infants With Localized Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group Int J Radiat Oncol Biol Phys103 (1): 19-27
Localized vaginal/uterine rhabdomyosarcoma-results of a pooled analysis from four international cooperative groups Pediatr Blood Cancer65 (9): e27096
45 Gy is not sufficient radiotherapy dose for Group III orbital embryonal rhabdomyosarcoma after less than complete response to 12 weeks of ARST0331 chemotherapy: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group Pediatr Blood Cancer64 (9):
Sonic hedgehog regulation of Foxf2 promotes cranial neural crest mesenchyme proliferation and is disrupted in cleft lip morphogenesis Development144 (11): 2082-2091
Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group Cancer123 (12): 2368-2375
Is 45 Gy a Sufficient Radiation Therapy Dose for Unresected Orbital Embryonal Rhabdomyosarcoma? A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group Int J Radiat Oncol Biol Phys96 (2S): E548
Final Report of a Prospective Clinical Trial of Cardiac Sparing Whole-Lung Intensity Modulated Radiation Therapy in Patients With Metastatic Pediatric Tumors Int J Radiat Oncol Biol Phys96 (2S): S118-S119
Serologic response and clinical efficacy of influenza vaccination in children and young adults on chemotherapy for cancer Pediatr Blood Cancer63 (11): 2011-8
Histology, Fusion Status, and Outcome in Alveolar Rhabdomyosarcoma With Low-Risk Clinical Features: A Report From the Children's Oncology Group Pediatr Blood Cancer63 (4): 634-9

David O. Walterhouse, MD

David O. Walterhouse, MD

Section Head, Oncology; Attending physician, Hematology/Oncology; Richard A. Perritt, MD Professorship in Cancer and Blood Disorders

Associate Professor of Pediatrics, Northwestern University Feinberg School of Medicine

Interim Director, Cancer Biology & Epigenomics Program, Stanley Manne Children's Research Institute

Appointments & Referrals

1.800.543.7362 (1.800.KIDS DOC)

About Me

Specialties, Programs & Conditions

Education & Training

Research

Publications

Call for Insurance information: 1.800.543.7362

Location